Calcium ion entry through voltage-gated calcium channels is essential for cellular signalling in a wide variety of cells and multiple physiological processes. Perturbations of voltage-gated calcium channel function can lead to pathophysiological consequences. Calcium binding proteins serve as calcium sensors and regulate the calcium channel properties via feedback mechanisms. This review highlights the current evidences of calcium binding protein-mediated channel regulation in human diseases.
Introduction
Calcium (Ca 2+ ) entry via voltage-gated calcium channels (VGCCs), conveys the electric signals to intracellular transduction cascades in a wide variety of cells including neurons, muscle cells and endocrine cells [1] . Ca 2+ dependent-signalling cascades are largely mediated by Ca 2+ binding proteins [2, 3] , and are essential for multiple cellular and subcellular processes in physiological conditions. Perturbations of VGCCs functions can cause abnormity of cellular events, leading to pathological consequences. Ca 2+ binding proteins mediate Ca
2+
-dependent signal transduction pathways and regulate Ca 2+ influx via the VGCCs in Ca 2+ -dependent feedback mechanisms. VGCCs are classified into L-, N-, P/Q-, R-, and T-types, based on their distinct electrophysiological and pharmacological properties [4, 5] . VGCCs are heteromultimeric protein complexes composed of a pore forming α 1 and four distinct auxiliary subunits: α 2 , δ, β, and γ subunits [4] [5] [6] [7] . Mammalian α 1 subunits are encoded by at least 10 distinct genes [6, 7] . The high voltage-activated VGCCs include Ca V 1 and Ca V 2 subfamilies. The Ca V 1 subfamily (Ca V 1.1 to Ca V 1.4) conducts L-type Ca 2+ current and includes the channels containing α 1S , α 1C , α 1D , and α 1F subunits. The Ca V 2 subfamily (Ca V 2.1 to Ca V 2.3) conducts P/Q-type, N-type, and R-type Ca 2+ currents, through the channels containing α 1A , α 1B , and α 1E subunits, respectively. The Ca V 3 subfamily (Ca V 3.1 to Ca V 3.3) conducts low voltage-activated T-type Ca 2+ current mediated by the channels containing α 1G , α 1H , and α 1I subunits, respectively. The cell-and tissuespecific expression of these subunits allows for a vast variety of the channel subtypes exhibiting distinct functions. Ca 2+ -binding proteins containing EF-hand Ca 2+ binding motifs regulate mostly high voltage-activated VGCCs [8] [9] [10] [11] [12] . The EF-hand motif is a conserved Ca 2+ -binding structure, spanning a region of 30-35 amino acids containing a 12-residue Ca 2+ binding loop flanked by the N-and C-terminal α-helix regions which are differentially exposed in the presence of Ca 2+ [3, 13, 14] . -binding proteins may achieve their cellular effects through Ca 2+ -dependent or Ca 2+ -independent signalling mechanisms [16, 17] (Figure 1 ). Many EF-hand Ca
-binding proteins alter Ca 2+ kinetics directly through regulation of VGCC properties [8] [9] [10] [11] [12] . With the availability of human genetic databases and advanced molecular technologies, growing evidences suggest that dysfunctions in Ca 2+ -binding protein mediated VGCC regulation may be one of the mechanisms leading to human diseases. The best studied Ca 2+ binding protein that regulates VGCCs is CaM [18] [19] [20] . CaM contains 4 functional EF-hand motifs [21, 22] , and regulates VGCCs properties in an enzymeinhibitor like fashion [23] . CaM binds to various high-voltage activated VGCCs and causes the Ca 2+ -dependent inactivation (CDI) [8, 9, 24, 25] or Ca 2+ -dependent facilitation (CDF) [10, 12, 26] ( Figure 1 ). In brief, CaM has a higher binding affinity to Ca 2+ in the N-lobe than the C-lobe EF-hand motifs. This allows for antagonistic regulation of the Ca 2+ channel through differential Ca 2+ binding to CaM [27] . Specifically, CDI of Ca V 1.2 channels [8, 9, 24] and CDF of Ca V 2.1 channels depend on Ca
binding to the C-lobe of CaM [10, 27] . Conversely, Ca 2+ binding to the N-lobe of CaM induces CDI of Ca V 2.1 [10, 12, 28] , Ca V 2.2 [10, 12] , and Cav2.3 [10] type channels. The differential regulatory effects of CaM on VGCCs are likely due to different conformational changes in the structure of CaM following Ca 2+ binding at alternate sites. CaM-mediated regulation of the presynaptic VGCCs results in a dual feedback regulation. The cellular and molecular mechanisms underlying CaM mediated VGCC regulation have been extensively reviewed previously [18] [19] [20] . FHM is characterized by recurrent migraines and includes visual disturbance, sensory loss, hemiparesis and ataxia. FHM type 1 is an autosomal dominant type of migraine with aura and hemiparesis, which is linked to the VGCC α 1 -subunit gene, CACNL1A4 encoding Ca V 2.1 [29] [30] [31] . All five FHM1 mutations change the biophysical properties of Ca V 2.1 channels, leading to both gain and loss of P/Q-type channel func tion [32, 33] . Specifically, single channel recording showed that the mutations enhanced the open probability of the Ca V 2.1 channels and shifted the activation gating of the channel to more negative voltages, allowing increased Ca 2+ influx at more negative membrane potentials in cerebellar neurons [33, 34] . Common treatments with Ca 2+ channel blockers, such as verapamil, is effective in some FHM1 patients, carrying the CACNA1A mutations due to decreased open probability of P/Q-type Ca V 2.1 channels and reduced Ca 2+ influx [35] . Consistent with reports of increased open-channel probability [32, 33] , a recent study showed that FHM-1 missense mutants of the C-terminus in Ca V 2.1 subunit, R192Q and S218L, permitted a larger Ca 2+ influx during action potentials than the wildtype channels in the cerebellar neurons [36] . Interestingly, these FHM-1 gain-of-function missense mutations characteristically occlude CDF of human Ca V 2.1 channels in both recombinant preparations and the cerebellar Purkinje cells. The altered CDF of Ca V 2.1 channels coincided with a decrease in short-term synaptic facilitation at the parallel fiberto-purkinje cell synapse in the cerebellum in FHM-1 mutant mice [36] . The compelling evidence suggests that FHM-1 gainof-function missense mutations of Ca V 2.1 channels favour a constitutively facilitated state that prevents further Ca 2+ -dependent CaM-mediated channel facilitation. It is hypothesized that disruption of Ca V 2.1 CDF may cause the cerebellar ataxia-associated FHM-1 due to an imbalance between excitatory and inhibitory inputs to the cerebellar Purkinje cells. This disruption suppresses the intrinsic pacemaker activity of these cells, thus leading to motor deficits [36] . The knock-in [34] , and it is thus important to demonstrate whether the cortical hyper-excitability is also associated with perturbation of CDF of the mutant Ca V 2.1 in future studies.
CaBPs mediated L-type channel inactivation
CaBPs consist of 8 members (CaBP 1-8) and are considered similar to CaM in that they bear four recognizable, but not necessarily functional EF-hands [37] . CaBP1, also known as caldendrin (a splice variant of CaBP1) [38] , has ~50% sequence homology to CaM and is widely expressed in the brain, including the cerebral cortex, hippocampus, in the cone bipolar and amacrine cells of the retina [39] , and in the inner hair cells. CaBP1 interacts with Ca V 2.1 P/Q -type channels [40, 41] , and L-type channels [42] . CaBP1 accelerates inactivation kinetics, prevents CaM-induced Ca V 2.1 channel facilitation, and shifts the voltage-dependent activation of Ca V 2.1 channels [40] . These effects of CaBP1 are mediated by binding to the CaM-binding IQ-domain in the α 1A subunit of Ca V 2.1 channels. CaBP1 binding to the CaM binding domain (CBD) of α 1A causes a significantly faster inactivation of Ca V 2.1 channel than CaM.
CaBPs regulate L-type channels in a Ca 2+ -independent manner [40, [42] [43] [44] (Figure 1 ), in contrast to CaM. CaBP1 and CaBP4 act as negative regulators to compete with CaM binding to the C-terminal IQ motif in the Ca V 1.2 and Ca V 1.3 subunit [42, [44] [45] [46] . CaBP1 also interacts with the N-terminal domain of Ca V 1.2 to prolong the channel activation, independent of CaM effect [42, 44] . Some CaBPs, such as CaBP1 and CaBP4, have the capacity to negatively regulate influx of Ca 2+ through a direct inhibitory interaction with plasma member P/Q-type channels in cochlear cells [45] [46] [47] . In the inner ear, at least 4 CaBPs have been found in hair cells, including CaBP1, CaBP2, CaBP4 and CaBP5. Sustained activation of presynaptic Ca V 1.3 channels triggers graded changes in neurotransmitter release which is required for sound detection [46] . CaBP1 binding to Ca V 1.3 channels on CaM interaction sites, induced a stronger, than CaBP4, inhibition of Ca 2+ -dependent channel inactivation [46] . Closely co-localization between CaBP1 and Ca V 1.3 at the presynaptic ribbon synapse of adult inner hair cells further suggests CaBP1-mediated inhibitory effect on Ca 2+ -dependent inactivation of Ca V 1.3 channel is critical for auditory transmission [46] . CaBP4 [48] and CaBP5 [49] regulates L-type channels in photoreceptors. CaBP4 is located at the photoreceptor synaptic terminals in the retina, and is important for developing and sustaining synaptic transmission to bipolar cells [43] . CaBP4 regulates Ca V 1.4 channel and shifts the activation of Ca V 1.4 to more hyperpolarized potentials through a direct interaction with the C-terminal domain of the Ca V 1.4 channel protein.
CaBP4
-/-mice exhibited visual deficits similar to that caused by dysfunction of Ca V 1.4 channels [43, 50, 51] . CaBP4, like CaBP1, is found to interact with CaM-binding IQ domain in Ca V 1.3 to dampen the inactivation of the channel [40, 46] . CaBP4 has the capacity to eliminate even the baseline Ca 2+ dependent inactivation of Ca V 1.3 [45] . Phosphorylation of S37 of CaBP4 by protein kinase Cζ in retina regulates Ca V 1.3, likely by facilitating the low-affinity interaction which exerts inhibitory regulation of Ca V 1.3 channel inactivation [48] . Phosphorylation of CaBP4 is critical for tuning presynaptic Ca 2+ signals required for lightinduced neurotransmitter release. Incomplete congenital stationary night blindness (CSNB2) is linked to mutations in both CaBP4 [52, 53] and Ca V 1.4 [54] [55] [56] . Interrelation between CaBP4 and Ca V 1.4 in CSNB2 remains to be determined.
Bestrophin-1 mediated Ca V 1.3 modulation in macular degeneration
Bestrophins are a family of calcium-activated chloride channels [57] encoded with VMD2 (Best vitelliform macular dystrophy-2) gene on chromosome 11q13 [58] . Human bestrophin-1 (hBest1) is a founding member of the family and contains one EF-hand (EF1, 350-390) at the C-terminal and a regulatory domain adjacent to EF1 that is required for Ca 2+ activation of the channel [59] . EF1 has a slightly higher Ca
2+
-binding affinity than the third EF hand of CaM and lower affinity than the second EF hand of troponin C. Mutations in hBest1 are involved in ~100 human diseases [58] . Retinal cell death, induced by glaucoma, diabetic reinopathy and age-related macular degeneration are primarily caused by a form of metabolic stress which results from a lack of nutrient supply. This process is initiated primarily through the activation of NMDA receptors with a subsequent influx of Ca 2+ and Na + ions into the cells [60] . The close relationship between ataxia and macular degeneration suggests that these disorders may share a common molecular network [61] . Oxidative stress, an important cause of retinal pigmental eipithelium death and subsequent age-related macular degeneration, induces calcium overload and leads to cell injury [62] . Oxidative stress induced elevation of Ca 2+ level is sensitive to VGCC blocker [62] , suggesting the role of VGCCs in retinal cell death.
The hBest1 is localized at the basolateral plasma membrane of the retinal pigment epithelium cells [63] . Mutations of the hBest1 gene are associated with macular degeneration [58] . Bestrophin-1 is co-localized with Ca V 1.3 channels and the auxiliary β4-subunit in the cell membrane in the retinal pigment epithelium, and inhibits Ca V 1.3 channels via a direct interaction with the Ca V β4 subunit [64, 65] . Mutations of hBest1 on P330 and P334 prevented Best1-mediated inhibition of Ca V 1.3 [64, 65] . These findings provide new insights into the mechanisms of the retinal degeneration involved in hBest1-mediated Ca V 1.3 channel regulation.
Calcineurin regulation of Ca 2+ channels in human diseases
Calcineurin is a calcium-dependent phosphatase activated by Ca 2+ /CaM [66] . It is a heterodimer and consisted of a 59 kDa catalytic subunit and a 19 kDa Ca 2+ -binding regulatory subunit. Calcineurin regulatory subunit is encoded with four putative EF-hand Ca 2+ -binding motifs [33] . The high-affinity Ca 2+ binding site has a K d of ~24 nmol/L to Ca 2+ whereas three low-affinity binding sites have a K d of 15 µmol/L to Ca 2+ [33] . Calcineurin regulates L-type channels in both myocytes [67] and www.nature.com/aps Nejatbakhsh N et al Acta Pharmacologica Sinica npg neurons [68, 69] .
Calcineurin regulation of Ca V 1.2 L-type channel in cardiac hypertrophy Ca 2+ signalling pathways play a critical role in the development of cardiac hypertrophy, one of the predisposing factors related to hypertension and development of heart failure. The downstream effector of calcineurin, NFAT signalling transduction pathway, plays a critical role in pathological cardiac hypertrophy response [70, 71] . L-type Ca V 1.2 channels play an important role in blood pressure and development of myogenic tone. In cardiac muscles, L-type currents through Ca V 1.2 channels stimulate the excitation-contraction coupling. The C-terminus of this channel serves an autoinhibitory role to mediate the fight-or-flight response. Inactivation of Ca V 1.2 was found to reduce mean arterial blood pressure in mice and there was a severe dampening of response to penylephrine and angiotensin II, due to a significant portion of penylephrine-induced resistance being dependent on calcium influx through the Ca V 1.2 channel [72] . The truncation in the distal C-terminus of the α 1 subunit of Ca V 1.2 leads to 10-15 fold increase in channel activity in mammalian cell lines [73] . The increased force of contraction during the fightor-flight response is thought to be mediated by regulation of Ca V 1.2 channels via activation of secondary systems which act to phosphorylate the channel [74] . Deletion of this C-terminus causes a reduction in Ca 2+ currents, as a result of lower surface expression of the channel, and leads to development of cardiac hypertrophy and premature death after E15 during embryonic development in mice [25] . Recently, an EF-hand containing Ca 2+ and integrin-binding protein-1 (CIB1) was found to specifically enhance cardiac pathological hypertrophy, without a role in altering physiological hypertrophy, through a regulation of calcineurin interaction with the sarcolemma [75] . One mechanism of calcineurin function is thought to be via L-type channels, which mediates Ca 2+ influx into cardiomyocytes. Transgenic mice expressing an activated form of calcineurin were found to exhibit an enhanced I Ca density compared with the non-transgenic littermates and to have a faster kinetics of I Ca inactivation [67] . Calcineurin can directly bind to both N-and C-termini (a.a. 1943-1971) of Ca V 1.2 channels, and dephosphorylate the channels, which in turn increase the channel conductance [76] . Magnesium ions (Mg 2+ ) bind to the C-terminal EF-hand to inhibit Ca V 1.2 channels, thereby reducing Ca 2+ influx to maintain the intracellular Ca 2+ at low levels [77] . Supplement of Mg 2+ during global ischemia resulted in myocardial protection and improved functional recovery [78] . These evidences suggest that calcineurin serves as a key modulator of Ca 2+ -dependent pathways via regulation of Ca V 1.2 activities and in turn mediates the pathological electrical remodelling in cardiac hypertrophy.
Calcineurin regulation of L-type channels in neurodegenerative diseases
Calcineurin selectively enhances L-type channel activity in hippocampal neurons [68, 69] . Application of FK506, an inhibitor of calcineurin, reduces high-voltage-activated Ca 2+ current via L-type, but not P/Q-or N-type channels [68] . PKA and calcineurin bind to A-kinase anchoring protein 79/150 (AKAP79/150), which interact with endogenous and recombinant Ca V 1.2 channels in hippocampal neurons and HEK293 cells, respectively [66] . Disruption of AKAP79/150-calcineurin anchoring increases Ca 2+ current amplitude [66] . In contrast to CaM, calcineurin does not affect Ca 2+ -dependent inactivation of the neuronal L-or N-type channels; this conclusion is based on the findings that FK506 has no effect on the time-course of Ca 2+ current inactivation of L-type channel in rat pituitary tumor cell line (GH3) and N-type channels in chicken dorsal root ganglion neurons, while Ca 2+ -dependent inactivation of the channels is prevented by Ca 2+ chelator EGTA [79] . Calcineurin promotes dephosphorylation of 3', 5'-cyclic AMP response element binding protein (CREB) [29] . Overexpression of calcineurin prevents [30] and inhibition of calcineurin enhances long-term memory formation [31, 80] . The activity of calcineurin increases in the hippocampus during aging, and L-type channel block reduces calcineurin activity [81] . Cleavage of calcineurin by Ca 2+ -sensitive protease calpain [82] enhances its phosphatase activity, which coincides with an increase in the number of neurofibrillary tangles in human brains of patients with Alzheimer's disease [83] . Interestingly, amyloid-β protein also increases the activity of calcineurin, leading to dephosphorylation of the proapototic protein BAD (Bcl-2/Bcl-X L -antagonist) causing cell death [84] and subsequent activation of apoptotic pathways in Alzheimer's disease [85] . Calcineurin activity is implicated in age-related Ca 2+ dysre gula tion in neurodegenerative disorders [69] . However, the role of EF-hand motifs in calcineurin-enhanced L-type channel activation, and the causal relation between calcineurin and VGCC regulation in degenerative disorders remain to be further investigated.
Perspectives and future directions
Functional diversity within related Ca 2+ -binding proteins may enhance the specificity of Ca 2+ signalling by VGCCs in different cellular contexts. These channels undergo feedback mechanisms by Ca 2+ -dependent facilitation or inactivation. Such feedback is largely mediated by Ca 2+ binding proteins. Increasing evidences demonstrate that the diverse and integrative roles of the abundant calcium binding proteins in VGCC regulation and Ca 2+ signalling may be attributed to human diseases. However, our understanding of the role of such regulation in human diseases is rather limited, due to the complexity of the intracellular protein networks in which integrative functions of Ca 2+ binding proteins must alter continuously to fit to the dynamic changes of Ca 2+ signalling. Many Ca 2+ binding proteins have been found to regulate VGCCs, however, little is known about how such regulations are related to the pathophysiological processes. For instance, neuronal Ca 2+ sensor-1/frequenin-1 (NCS-1/frq1) containing three functional EF-hand Ca 2+ binding motifs [15, [86] [87] [88] exhibits a 10 fold higher affinity for Ca 2+ than CaM [89] . NCS-1 is highly localized at the presynaptic terminal of the vertebrates [90] [91] [92] [93] [94] [95] and [88, [96] [97] [98] , and facilitates synaptic transmission. It increases the P/Q-type Ca 2+ current in the Calyx of Held of the giant presynaptic terminal [90] , and regulates the presynaptic N-type channels in motoneurons [99] and growth cone VGCCs in Lymnaea neurons [100, 101] . Another example is visinin-like protein-2 (VILIP-2), a highly homologous subfamily of NCS proteins and capable of undergoing Ca 2+ -myristoyl switch [102, 103] .
VILIP-2 slows inactivation [104] and enhances facilitation [105] of the presynaptic P/Q-type Ca 2+ channels, by a direct interaction with the CBD of the C-terminus of Ca V 2.1. However, whether and how NCS-1 or VILIP-2-mediated VGCC regulation contributes to human diseases remain unclear. Conversely, down-regulation of VILIP-1 has been reported in several types of human cancers [106, 107] , and in heart failure/cardiac hypertrophy [108] . However, whether VILIP-1 effect is associated with VGCC regulation is unknown. Thus, it is necessary to further investigate if there is interrelation between VGCC regulation by Ca 2+ binding proteins and human diseases.
Dysregulation of Ca 2+ homeostasis leads to pathophysiological processes related to human diseases. For instance, a disruption of basal and stimulus-dependent Ca 2+ levels has been reported in brains of patients suffering from Alzheimer's disease [109] . The level of Ca 2+ -sensitive protease calpain-1 in the prefrontal cortex is 3-fold higher in the postmorten brains of individuals with Alzheimer's disease, than those with other neurodegenerative disorders, such as Huntington's or Parkinson's disease. Calpain-1 activates Ca 2+ -sensitive phosphatase calcineurin by cleaving lysine501 at the C-terminal [83] .
The abnormally enhanced calpain and truncated calcineurin activities correlate with the level of secreted amyloid precursor protein and progression of Alzheimer's disease [110, 111] .
Thus, disruption of Ca 2+ homeostasis in neuropathology of Alzheimer's disease may be mediated by hyperactivity of calpain-1 and calcineurin. Similarly, α-synuclein, a key protein in the pathophysiology of Parkinson's disease [112, 113] , binds to calmodulin in a Ca 2+ -dependent manner [114] . α-Synucleincalmodulin interaction accelerates fibrilization of synuclein, crucial for forming the core of Lewy bodies. α-Synuclein also colocalizes with other Ca 2+ -binding proteins, including calbindin and parvalbumin [115] , implicating the significance 
